Search

Author/Creator Hulstrøm, Veronica

1. 119. Safety and Reactogenicity of an Investigational Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine for Adults ≥ 60 Years of Age (RSVPreF3 OA): an Interim Analysis at 6 Months after Vaccination. (15th December 2022)

Authors:
Schwarz, Tino F; Hwang, Shinn-Jang; Ylisastigui, Pedro P; Liu, Chiu-Shong; Takazawa, Kenji; Yono, Makoto; Ervin, John E; Andrews, Charles; Fogarty, Charles; Eckermann, Tamara; Vicco, Miguel; Lievens, Marc; Maréchal, Céline; Nakanwagi, Phoebe; Hulstrøm, Veronica
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 96. A Candidate Respiratory Syncytial Virus (RSV) Prefusion F Protein Investigational Vaccine (RSVPreF3 OA) Is Immunogenic when Administered in Adults ≥ 60 Years of Age: Results at 6 Months after Vaccination. (15th December 2022)

Authors:
Schwarz, Tino F; Hwang, Shinn-Jang; Ylisastigui, Pedro P; Liu, Chiu-Shong; Takazawa, Kenji; Yono, Makoto; Ervin, John E; Andrews, Charles; Fogarty, Charles; Eckermann, Tamara; Collete, Delphine; de Heusch, Magali; Schrevel, Nathalie De; Salaun, Bruno; Lievens, Marc; Maréchal, Céline; Nakanwagi, P...
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. LB745. Respiratory Syncytial Virus (RSV) Prefusion F Protein Candidate Vaccine (RSVPreF3 OA) is Efficacious in Adults ≥ 60 Years of Age (YOA). (15th December 2022)

Authors:
Ison, Michael G; Papi, Alberto; Langley, Joanne M; Lee, Dong-Gun; Leroux-Roels, Isabel; Martinon-Torres, Federico; Schwarz, Tino F; Van Zyl-Smit, Richard N; Dezutter, Nancy; De Schrevel, Nathalie; Fissette, Laurence; David, Marie-Pierre; Van Der Wielen, Marie; Kostanyan, Lusine; Hulstrøm, Veronica
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial. (29th July 2022)

Authors:
Leroux-Roels, Isabel; Davis, Matthew G; Steenackers, Katie; Essink, Brandon; Vandermeulen, Corinne; Fogarty, Charles; Andrews, Charles P; Kerwin, Edward; David, Marie-Pierre; Fissette, Laurence; Vanden Abeele, Carline; Collete, Delphine; de Heusch, Magali; Salaun, Bruno; De Schrevel, Nathalie; Ko...
Journal:
Journal of infectious diseases
Issue:
Volume 227:Number 6(2023)
Page Start:
761
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗